Kukje Pharma Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kukje Pharma Co Ltd with three other
companies in this sector in South Korea:
Hyundai Pharmaceutical Company Limited
sales of 120.02 billion Korean Won [US$112.46 million]
of which 86%
Reyon Pharmaceutical Co Ltd
(121.85 billion Korean Won [US$114.17 million]
Nutri Biotech Co Ltd
(120.78 billion Korean Won [US$113.17 million]
of which 100%
was Manufacture & Sales of Health Food).
Kukje Pharma Co Ltd reported sales of 120.68 billion Korean Won (US$113.08 million)
December of 2016.
increase of 2.6%
versus 2015, when the company's sales were 117.64 billion Korean Won.
Despite this increase, sales are still
below the level achieved in 2014, when Kukje Pharma Co Ltd
reported sales of 122.43 billion Korean Won.
Sales of Pharmaceutical saw an increase
that was more than double the company's growth rate: sales were up
8.3% in 2016, from
105.25 billion Korean Won to 114.00 billion Korean Won.
Not all segments of Kukje Pharma Co Ltd experienced an increase in sales in 2016:
sales of Cosmetics fell 84.5% to 991.59 million Korean Won.
Kukje Pharma Co Ltd also experienced decreases in sales in
Other (down 4.9% to 5.69 billion Korean Won)